Another study revealed that miR-30 induces the degradation of BCR/ABL1 mRNAs by binding directly to their 3′UTR, which was downregulated in CML patients less responsive to IM [152]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.